《港股開市》恆指低開54點 阿裏回吐 友邦揚逾4%
美股在債息回軟下先升後倒跌,道指反覆跌313點或0.9%。港股早市隨外圍低開,恆指低開54點或0.22%,報24,897點;國指低開52點或0.6%,報8,708點;恆生科技指數低開56點或0.95%,報5,840點。
多隻科技股回吐,阿裏巴巴(09988.HK)低開4.1%報126.1元,騰訊(00700.HK)低開0.6%報468.8元,美團(03690.HK)低開1.3%報235元,小米(01810.HK)低開0.5%報18.8元,京東(09618.HK)高開0.7%報302元,百度(09888.HK)高開0.6%報159.3元,網易(09999.HK)低開3.4%報162元。
內房股方面,碧桂園(02007.HK)擬溢價16%發行可換股債券淨籌38.6億元,股價低開0.9%報6.9元。恆大(03333.HK)指風險化解委員會擬增聘中介機構,助開展債務風險化解工作,該股平開報1.8元。
匯控(00005.HK)低開1.5%報53.6元,港交所(00388.HK)平開報474.2元,友邦(01299.HK)高開4.3%報92.5元。油價回落,中石化(00386.HK)及中石油(00857.HK)各低開1.5%,中海油(00883.HK)低開1.1%。
復星醫藥(02196.HK)獲藥品專利池組織許可生產抗新冠口服藥「Molnupiravir」原料藥和成品藥,復星醫藥今早高開9.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.